Product Categories
| Country: | China |
|---|---|
| Tel: | 021-61350663 |
| Mobile: | 13052117465 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| KML-29 | C24H21F6NO7 | 1380424-42-9 | Details |
| Salermide | C26H22N2O2 | 1105698-15-4 | Details |
| JZL184 | C27H24N2O9 | 1101854-58-3 | Details |
| MK8931 | C18H18N4OS | 1613380-81-6 | Details |
| (Nidufexor)EOS-61760 | C27H22ClN3O4 | 1773489-72-7 | Details |
| SC79 | C17H17ClN2O5 | 305834-79-1 | Details |
| C646 | C24H19N3O6 | 328968-36-1 | Details |
| Scriptaid (GCK1026) | C18H18N2O4 | 287383-59-9 | Details |
| Exatecan mesilate | C25H26FN3O7S | 169869-90-3 | Details |
| Treprostinil | C23H34O5 | 81846-19-7 | Details |
| BMS-935177 | C31H26N4O3 | 1231889-53-4 | Details |
| RGFP 966 | C21H19FN4O | 1357389-11-7 | Details |
| Erastin | C30H31ClN4O4 | 571203-78-6 | Details |
| Ro31-8220MsOH | C25H23N5O2S | 138489-18-6 | Details |
| TP-3654 | C22H25F3N4O | 1361951-15-6 | Details |
| JNJ-42041935 | C12H6ClF3N4O3 | 1193383-09-3 | Details |
| AZ-33 | C25H27N3O6S | 1370290-34-8 | Details |
| TUG 891 | C23H21FO3 | 1374516-07-0 | Details |
| TM 5275 sodium salt | C28H29ClN3NaO5 | 1103926-82-4 | Details |
| RO462005 | C23H27N3O6S | 150725-87-4 | Details |
| GO6983 | C26H26N4O3 | 133053-19-7 | Details |
| VU 0364770 | C12H9ClN2O | 61350-00-3 | Details |
| RQ 00203078 | C21H13ClF6N2O5S | 1254205-52-1 | Details |
| CP544326 | C24H22N4O5S | 752187-80-7 | Details |
| GSK137647A | C16H19NO3S | 349085-82-1 | Details |
| fluoroclebopride | C20H23ClFN3O2 | 154540-49-5 | Details |
| APD597 | C21H29N5O6S | 897732-93-3 | Details |
| R-112 | C16H13FN4O2 | 575474-82-7 | Details |
| RAF709 | C28H29F3N4O4 | 1628838-42-5 | Details |
| Olopatadine Hydrochloride | C21H24ClNO3 | 140462-76-6 | Details |
| UM-164 | C30H31F3N8O3S | 903564-48-7 | Details |
| CEP-40783 | C31H26F2N4O6 | 1437321-24-8 | Details |
| A-196 | C18H16Cl2N4 | 1982372-88-2 | Details |
| LLY-283 | C17H18N4O4 | 2040291-27-6 | Details |
| UNC0379 | C23H35N5O2 | 1620401-82-2 | Details |
| B-Raf inhibitor 1 dihydrochloride | C26H21Cl3N8 | 1191385-19-9 | Details |
| 3-Cyano-7-ethoxycoumarin | C12H9NO3 | 117620-77-6 | Details |
| ML204 | C15H18N2 | 5465-86-1 | Details |
| N6-cyclohexyl-N2-(2-methyl-4-morpholinophenyl)-9H-purine-2,6-diamine | C22H29N7O | 1246529-32-7 | Details |
| U-104 | C13H12FN3O3S | 178606-66-1 | Details |
| JH-II-127 | C19H21ClN6O3 | 1700693-08-8 | Details |
| Isoxazole 9 (ISX-9) | C11H10N2O2S | 832115-62-5 | Details |
| MSX-122 | C16H16N6 | 897657-95-3 | Details |
| NIBR189 | C21H21BrN2O3 | 1599432-08-2 | Details |
| SGC707 | C16H18N4O2 | 1687736-54-4 | Details |
| XY1 | C17H19N3O2 | 1624117-53-8 | Details |
| 3-(4-morpholino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)benzonitrile | C17H15N5O | 1527473-33-1 | Details |
| SP2509 | C19H20ClN3O5S | 1423715-09-6 | Details |
| BMS-3 | C17H12Cl2F2N4OS | 1338247-30-5 | Details |
| GPR39-C3 | C18H19ClN6O2S | 1621175-65-2 | Details |
| HPI-4 | C17H9Cl2N3O2 | 302803-72-1 | Details |
| RS-1 | C20H16Br2N2O3S | 312756-74-4 | Details |
| M2I-1 | C19H24N4O4S | 312271-03-7 | Details |
| Bohemine | C18H24N6O | 189232-42-6 | Details |
| 2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine hydrate trihydrochloride | C28H38N6O2 | 935693-62-2 | Details |
| TA-01 | C20H12F3N3 | 1784751-18-3 | Details |
| PCI 34051 | C17H16N2O3 | 950762-95-5 | Details |
| BMS-5 | C17H14Cl2F2N4OS | 1338247-35-0 | Details |
| GSK | C20H24Cl3N3O | 1010411-21-8 | Details |
| PMPA(NAALADaseinhibitor) | C6H11O7P | 173039-10-6 | Details |
| E6005 | C26H24N4O5 | 947620-48-6 | Details |
| C188-9 | C27H21NO5S | 432001-19-9 | Details |
| SF-2523 | C19H17NO5S | 1174428-47-7 | Details |
| SCH23390 | C17H19Cl2NO | 87134-87-0 | Details |
| HG-9-91-01 | C32H37N7O3 | 1456858-58-4 | Details |
| Takinib | C18H18N4O2 | 1111556-37-6 | Details |
| Monastrol | C14H16N2O3S | 254753-54-3 | Details |
| AT9283 | C19H23N7O2 | 896466-04-9 | Details |
| 5-(1-Methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-7H-Pyrrolo[2,3-d]pyrimidine | C14H16N6O | 1527473-30-8 | Details |
| ZL0420 | C16H16N4O2 | 2229039-45-4 | Details |
| PQR309 Bimiralisib | C17H20F3N7O2 | 1225037-39-7 | Details |
| HS1371 | C24H24N4O | 2158197-70-5 | Details |
| IITZ-01 | C26H23FN8O | 1807988-47-1 | Details |
| MI-503 | C28H27F3N8S | 1857417-13-0 | Details |
| TAS-120 | C22H22N6O3 | 1448169-71-8 | Details |
| I-BET151(GSK1210151A) | C23H21N5O3 | 1300031-49-5 | Details |
| ARV-825 | C46H47ClN8O9S | 1818885-28-7 | Details |
| dBET6 | C42H45ClN8O7S | 1950634-92-0 | Details |
| SB225002 | C13H10BrN3O4 | 182498-32-4 | Details |
| ODM203 | C26H21F2N5O2S | 1430723-35-5 | Details |
| blu667 | C27H32FN9O2 | 2097132-94-8 | Details |
| Treprostinil diethanolamine | C27H45NO7 | 830354-48-8 | Details |
| treprostinil sodium | C23H35NaO5 | 289480-64-4 | Details |
| Eldecalcitol | C30H50O5 | 104121-92-8 | Details |
| LevoMilnacipran hydrochloride | C15H23ClN2O | 175131-60-9 | Details |
| N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide | C25H35NO5S | 1474110-21-8 | Details |
| 2-[8-Chloro-6-(4-chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl] | C24H20ClN5O2 | 1505453-59-7 | Details |
| Ki2 0227 | C24H24N4O5S | 623142-96-1 | Details |
| BIIB057 HCl | C19H24ClN9O | 1370261-97-4 | Details |
| Nelonicline | C17H19N3OS | 1026134-63-3 | Details |
| SNX-5422 | C25H30F3N5O4 | 908115-27-5 | Details |
| Sparsentan (RE-021) | C32H40N4O5S | 254740-64-2 | Details |
| FK866 | C24H29N3O2 | 1198425-96-5 | Details |
| ETC-1002 | C19H36O5 | 738606-46-7 | Details |
| Derazantinib (ARQ 087) | C29H29FN4O | 1234356-69-4 | Details |
| Rogaratinib | C23H26N6O3S | 1443530-05-9 | Details |
| AZD0364 | C24H24F2N8O2 | 2097416-76-5 | Details |
| Lipofermata | C15H10BrN3OS | 297180-15-5 | Details |
| Ponesimod | C23H25ClN2O4S | 854107-55-4 | Details |
| Retro-2 | C19H16N2OS | 1429192-00-6 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 | ||||